maaf email atau password anda salah

Other Tempo Media
Majalah Tempo
Koran Tempo
Tempo.co
Subscribe

Nanobody Cure for Autoimmune Diseases

Monday, April 25, 2022

Novalia Pisesha invents an effective and affordable medical technology. University and post-graduate students look to her to study nanobody technology in curing autoimmune diseases.

arsip tempo : 176862984763.

Novalia Pisesha Rhogerry Deshycka . tempo : 176862984763.

IN her 15 years living in the United States, Novalia Pisesha always carried with her the promise she made to her aunt suffering from lupus. Her academic path in bioengineering started at the City College of San Francisco (CCSF) in California. Her dream was to find a proper cure for autoimmune diseases. “I promised my aunt that I would invent an effective medicine,” she said through a video conference call on Wednesday, April 20.  

...

Subscribe to continue reading.
We craft news with stories.

For the benefits of subscribing to Digital Tempo, See More

The Best Choice

Rp 750.000/12 months

  • *Flexible payment methods
  • *Unlimited access to Tempo Plus & Tempo Magz
Subscribe

Rp 386.280/6 months

  • *Auto-renews every 6 months
  • *Cancel at anytime
  • *Unlimited access to Tempo Plus & Tempo Magz
Subscribe

See Other Packages

Already a Subscribed? Log in here
To receive daily news by Email, Sign up for Tempo ID.

Dini Pramita

Diabetes Indonesian researcher Novalia Pishesha Women MIT Autoimmune Diseases Startup Biotechnology Immune System Biological Engineering
Prev Next

More Articles

More exclusive contents

  • January 12, 2026

  • January 5, 2026

  • December 29, 2025

  • December 22, 2025

Independent journalism needs public support. By subscribing to Tempo, you will contribute to our ongoing efforts to produce accurate, in-depth and reliable information. We believe that you and everyone else can make all the right decisions if you receive correct and complete information. For this reason, since its establishment on March 6, 1971, Tempo has been and will always be committed to hard-hitting investigative journalism. For the public and the Republic.

Login Subscribe